Picard Medical, Inc. Income Statement
PMI|1 years of annual SEC 10-K data (FY2025-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data. All figures from audited SEC 10-K filings.
Picard Medical, Inc. reported $5M in revenue and $27M in net loss for FY2025. Its profit margin was -546.6% in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 |
|---|---|
| Revenue | $4.9M |
| Cost of Revenue | $5.1M |
| Gross Profit | -$204.0K |
| SG&A Expense | $10.0M |
| R&D Expense | $3.0M |
| Operating Income | -$13.3M |
| Income Tax | $35.0K |
| Net Income | -$27.0M |
| EPS (Basic) | -$2.99 |
| Shares Outstanding | 7.9M |
| Gross Margin | -4.1% |
| Operating Margin | -268.4% |
| Profit Margin | -546.6% |